FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 1553953 · Received November 10, 2009

Report

Report Number
2027969-2009-01057
Event Type
Malfunction
Date Received
November 10, 2009
Date of Event
October 22, 2009
Report Date
November 10, 2009
Manufacturer
BIOSITE INCORPORATED
Product Code
JPA
PMA / PMN Number
021923
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

INRATIO PRECISION DATA PROVIDED BY END-USER LOT: DATE: (B)(6) 2009; CUSTOMER'S INRATIO = 4.30 INR; DOCTOR'S INRATIO = 3.50 INR; MEAN = 3.90 INR; SD = 0.57; %CV = 14.50. SINCE 14.50% CV IS LESS THAN 20%, INRATIO METER RESULTS PASS THE CRITERIA FOR PRECISION. NO FURTHER TESTING IS REQUIRED AT THIS TIME. CV% CALCULATION FROM COMPARISON TEST DATA PROVIDED BY END-USER REVEALED PRECISION CRITERIA HAD BEEN MET. PRODUCT DEFICIENCY WAS NOT ESTABLISHED. NO PRODUCT IS EXPECTED TO BE RETURNED. FURTHER TESTING IS NOT REQUIRED AT THIS TIME. AS OF 11/04/2009, 26 DISCREPANT RESULT COMPLAINTS WERE REPORTED FOR LOT #214530 YIELDING A COMPLAINT RATE OF 0.043%. DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (>0.07%) NO FURTHER ACTION IS REQUIRED AT THIS TIME. ON GOING TRENDING SHALL BE PERFORMED TO DETERMINE IF FURTHER ACTION IS WARRANTED. CORRECTIVE ACTION NOT REQUIRED AT THIS TIME AS PRODUCT DEFICIENCY WAS NOT ESTABLISHED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS: DATE: (B)(6) 2009; INRATIO: 4.3; LAB: 3.5.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA BIOSITE INCORPORATED 100071 214530

Patients

Seq Age Sex Outcome Treatment
1